Le Lézard
Classified in: Covid-19 virus

Global Interventional Pulmonology Market Insights & Forecasts 2024-2028 with Potential Impact of COVID-19 - Surging COPD Mortality Rate and Improving Training Programs Fueling Growth - ResearchAndMarkets.com


The "Global Interventional Pulmonology Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering.

The global interventional pulmonology market is forecasted to reach US$5.24 billion in 2028, rising at a CAGR of 5.81%, for the time period of 2024-2028

Factors such as growing incidence of lung cancer, rising CO2 emission, expansion of medical device industry, surging COPD mortality rate, increasing elderly population and increasing public awareness would drive the growth of the market. However, the market growth would be challenged by associated patients risk, high cost involved in the maintenance of equipment and entry barriers for new companies. A few notable trends may include rising healthcare expenditures, growing consumption of e-cigarettes and improving training programs for interventional pulmonologist.

Robotic bronchoscopy is emerging as a game changer in the interventional pulmonology market. Rapid and accurate diagnosis of lung cancer have become the need of the hour in the interventional pulmonology market. This is triggering the developments in robotic bronchoscopy platforms, consisting of a hand-held controller used to direct a small, flexible endoscope into the lung using a computer-assisted navigation. As a result of such developments, the overall global interventional pulmonology market would aid in near future.

China is emerging out as a prominent region in the global market due to accelerating aging population and changing disease patterns, along with the escalating demands from healthcare institutions. Other factors such as strong government policy support, continuous technology innovation and increasing public awareness are further likely to accelerate the market growth in the region and thereby would add to the overall global interventional pulmonology market in coming years.

Scope of the report

Company profiles of leading players

Key Target Audience

Key Attributes:

Report Attribute Details
No. of Pages 66
Forecast Period 2024 - 2028
Estimated Market Value (USD) in 2024 $4.18 Billion
Forecasted Market Value (USD) by 2028 $5.24 Billion
Compound Annual Growth Rate 5.8%
Regions Covered Global

Key Topics Covered:

1. Market Overview

1.1 Introduction

1.2 Interventional Pulmonology Procedures

1.3 Interventional Diagnosis Products for Lung Nodules

1.4 Breakdown of Interventional Pulmonology

2. Impact of COVID-19

2.1 Proposed Triage of Interventional Pulmonology Procedures During COVID-19.

2.2 Rise in Adoption of Healthcare Artificial Intelligence

2.3 Role of Single-use Bronchoscopes in COVID-19

3. Global Market Analysis

3.1 Global Interventional Pulmonology Market by Value

3.2 Global Interventional Pulmonology Market Forecast by Value

3.3 Global Interventional Pulmonology Market by Product

3.3.1 Global Electromagnetic Navigation Bronchoscopy Products Market by Value

3.3.2 Global Electromagnetic Navigation Bronchoscopy Products Market Forecast by Value

3.3.3 Global Interventional Pulmonology Diagnostics Products Market by Value

3.3.4 Global Interventional Pulmonology Diagnostics Products Market Forecast by Value

3.3.5 Global Interventional Pulmonology Therapeutic Products Market by Value

3.3.6 Global Interventional Pulmonology Therapeutic Products Market Forecast by Value

3.4 Global Bronchoscopy Procedure Volume

3.5 Global Bronchoscopy Procedure Volume Forecast

3.6 Global Bronchoscopy Procedure Volume by Region

4. Regional Market Analysis

4.1 China

4.1.1 China Interventional Pulmonology Navigation Device Market by Value

4.1.2 China Interventional Pulmonology Navigation Device Market Forecast by Value

4.1.3 China Interventional Pulmonology Navigation Device Market Forecast by Volume

4.1.4 China Bronchoscopy Procedure Volume

4.1.5 China Bronchoscopy Procedure Volume Forecast

4.2 The U.S.

4.2.1 The U.S. Bronchoscopy Procedure Volume

4.2.2 The U.S. Bronchoscopy Procedure Volume Forecast

4.3 Europe

4.3.1 Europe Bronchoscopy Procedure Volume

4.3.2 Europe Bronchoscopy Procedure Volume Forecast

4.4 ROW

4.4.1 ROW Bronchoscopy Procedure Volume

4.4.2 ROW Bronchoscopy Procedure Volume Forecast

5. Market Dynamics

5.1 Growth Drivers

5.1.1 Growing Incidence of Lung Cancer

5.1.2 Rising CO2 Emission

5.1.3 Expansion of Medical Device Industry

5.1.4 Surging COPD Mortality Rate

5.1.5 Increasing Elderly Population

5.1.6 Increasing Public Awareness

5.2 Key Trends & Developments

5.2.1 Rising Healthcare Expenditure

5.2.2 Growing Consumption of E-cigarettes

5.2.3 Improving Training Programs for Interventional Pulmonologist

5.3 Challenges

5.3.1 Associated Patient Risk

5.3.2 High Cost Involved in the Maintenance of Equipment

5.3.3 Entry Barrier for New Companies

6. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/vgijxm

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

at 16:15
Golub Capital BDC, Inc. ("GBDC," or the "Company"), a business development company , announced today that it obtained stockholder approval of the proposal related to its merger with Golub Capital BDC 3, Inc. ("GBDC 3") at a special meeting of the...

at 16:10
Capri Holdings Limited , a global fashion luxury group, today announced its financial results for the fourth quarter and full year fiscal 2024 ended March 30, 2024. Fourth Quarter Fiscal 2024 Highlights Revenue decreased 8.4% on a reported basis...

at 16:10
Vir Biotechnology, Inc. today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, at 11:00...

at 16:05
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced preclinical...

at 13:25
The "Asia-Pacific Artificial Intelligence/ Machine Learning Medical Device Market: Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific artificial intelligence/machine learning medical...

at 13:00
Las Vegas Sands  has contributed $225,000 through Sands Cares to the Asian Community Development Council (ACDC) for three key ACDC offerings including the Healthy Asian Pacific Islanders (HAPI) Medical Center, the API Language Link and developmental...



News published on and distributed by: